Hasil Filter

2677

Total database: 17430
Struktur (SMILES)
1588 (59.3%)
Target
1494 (55.8%)
Genomik
51 (1.9%)
Referensi
2677 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (2677)

Halaman 50 / 54
Thiopental Approved DB00599
small molecule | CAS: 76-75-5

A barbiturate that is administered intravenously for the induction of general anesthesia or for the production of complete anesthesia of short duration. It is also used for hypnosis and for the control of convulsive states. It has been used in neurosurgical p…

Kategori:
AnestheticsAnesthetics, GeneralAnesthetics, Intravenous +27
Target Protein:
Gamma-aminobutyric acid receptor subunit alpha-1Gamma-aminobutyric acid receptor subunit alpha-2Gamma-aminobutyric acid receptor subunit alpha-3 +9
Waktu Paruh3-8 hours
Vol. Distribusi-
Klirens-
Genetik -
Thiosulfuric acid Approved DB09499
small molecule | CAS: 13686-28-7

Thiosulfuric acid is available in its salt forms sodium thiosulfate and sodium thiosulfate pentahydrate. Sodium thiosulfate is part of the World Health Organization’s list of essential medicines, and it has a variety of industrial uses, including food preserv…

Kategori:
AcidsAnti-Infective AgentsAntidotes +14
Waktu ParuhThe half-life of th…
Vol. DistribusiThiosulfate has a m…
KlirensIn patients with fu…
Genetik -
Thonzonium Approved DB09552
small molecule | CAS: 25466-36-8

Thonzonium is a monocationic surface-active agent with surfactant and detergent properties. It is widely used as an additive to in ear and nasal drops to enhance dispersion and penetration of cellular debris and exudate, thereby promoting tissue contact of th…

Kategori:
AminesAmmonium CompoundsNitrogen Compounds +2
Target Protein:
V-type proton ATPase subunit C 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Thonzylamine Approved DB11235
small molecule | CAS: 91-85-0

Thonzylamine is an antihistamine and anticholinergic drug. It is available as combination products with [DB04837] or [DB00388] for temporary relief of symptoms of common cold, hay fever (allergic rhinitis) or other upper respiratory allergies.

Kategori:
Agents producing tachycardiaAntiallergic Agents, Excl. CorticosteroidsAnticholinergic Agents +11
Target Protein:
Histamine H1 receptorMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M2 +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Thrombin Approved DB11300
biotech

Also known as coagulation factor II, thrombin is a serine protease that plays a physiological role in regulating hemostasis and maintaining blood coagulation. Once converted from prothrombin, thrombin converts fibrinogen to fibrin, which, in combination with …

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsBlood and Blood Forming Organs +18
Target Protein:
Coagulation factor XICoagulation factor XIII A chainCoagulation factor XIII B chain +7
Waktu ParuhUnfortunately, litt…
Vol. DistribusiLittle has been rep…
KlirensAlthough little has…
Genetik -
Thrombin alfa Approved DB11572
biotech | CAS: 869858-13-9

Thrombin Alfa is a human coagulation protein produced via recombinant DNA technology from a genetically modified CHO cell line. Thrombin Alfa is identical in amino acid sequence and structurally similar to naturally occurring human thrombin. Thrombin Alfa pre…

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsBlood Coagulation Factors +12
Target Protein:
Coagulation factor VCoagulation factor VIIIFibrinogen alpha chain +2
Waktu ParuhFollowing intraveno…
Vol. DistribusiTraditional absorpt…
KlirensTraditional absorpt…
Genetik -
Thymol Approved DB02513
small molecule | CAS: 89-83-8

A phenol obtained from thyme oil or other volatile oils. It is used as a stabilizer in pharmaceutic preparations. It has been used for its antiseptic, antibacterial, and antifungal actions, and was formerly used as a vermifuge. (Dorland, 28th ed)

Kategori:
Anti-Infective AgentsAnti-Infective Agents, LocalAntifungal Agents +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Thyroid, porcine Approved DB09100
biotech

Thyroid extract is dried and powdered thyroid glands from pigs containing tiiodothyronine (T3) and thyroxine (T4) used to supplement low or absent thyroid activity.[A190831,L11755] Thyroid extract has been described in literature to treat hypothyroidism since…

Kategori:
Agents used to treat hypothyroidismThyroid Products
Target Protein:
Thyroid hormone receptor alphaThyroid hormone receptor beta
Waktu ParuhData regarding the …
Vol. DistribusiData regarding the …
KlirensData regarding the …
Genetik -
Tiagabine Approved DB00906
small molecule | CAS: 115103-54-3

Tiagabine is an anti-convulsive medication. It is also used in the treatment for panic disorder as are a few other anticonvulsants. Though the exact mechanism by which tiagabine exerts its effect on the human body is unknown, it does appear to operate as a se…

Kategori:
Anti-epileptic AgentAnticonvulsantsCentral Nervous System Agents +15
Target Protein:
Sodium- and chloride-dependent GABA transporter 1
Waktu Paruh7-9 hours
Vol. Distribusi-
Klirens* 109 mL/min [Healt…
Genetik -
Tianeptine DB09289
small molecule | CAS: 72797-41-2

Tianeptine is a drug used primarily in the treatment of major depressive disorder and has been studied in the treatment of irritable bowel syndrome (IBS) [A31983]. Structurally, it is classified as a tricyclic antidepressant (TCA), however, it possesses diffe…

Kategori:
Agents Causing Muscle ToxicityAgents that produce hypertensionAgents that reduce seizure threshold +20
Target Protein:
Mu-type opioid receptorSodium-dependent serotonin transporterGlutamate receptor 1 +2
Waktu ParuhApproximately 2.5 h…
Vol. Distribusi0.8 L/kg (0.77 +/- …
KlirensRapidly cleared by …
Genetik -
Tibolone Approved DB09070
small molecule | CAS: 5630-53-5

Tibolone is a synthetic steroid hormone drug, which is mainly non-selective in its binding profile, acting as an agonist primarily at estrogen receptors (ER), with a preference for ER alpha [L1874]. Tibolone (Livial, Org OD 14), produced by Organon (West O…

Kategori:
Anabolic AgentsAntineoplastic Agents, HormonalCardiovascular Agents +12
Target Protein:
Estrogen receptor
Waktu ParuhThe elimination hal…
Vol. Distribusi-
KlirensElimination of tibo…
Genetik -
Ticagrelor Approved DB08816
small molecule | CAS: 274693-27-5

Ticagrelor, or AZD6140, was first described in the literature in 2003.[A204170,A2903] Ticagrelor is an ADP derivative developed for its P2Y<sub>12</sub> receptor antagonism.[A2903] Unlike [clopidogrel], ticagrelor is not a prodrug.[A2903] It is marketed by As…

Kategori:
AnticoagulantsAntiplatelet agentsBlood and Blood Forming Organs +37
Target Protein:
P2Y purinoceptor 12
Waktu ParuhTicagrelor has a pl…
Vol. DistribusiThe steady state vo…
KlirensThe renal clearance…
Genetik -
Tigecycline Approved DB00560
small molecule | CAS: 220620-09-7

Tigecycline is a glycylcycline antibiotic developed and marketed by Wyeth under the brand name Tygacil. It was developed in response to the growing prevalence of antibiotic resistance in bacteria such as Staphylococcus aureus. It was granted fast-track approv…

Kategori:
Agents that produce neuromuscular block (indirect)Anti-Bacterial AgentsAnti-Infective Agents +7
Target Protein:
16S ribosomal RNA30S ribosomal protein S930S ribosomal protein S12 +3
Waktu Paruh27-43 hours
Vol. Distribusi-
Klirens-
Genetik -
Tildrakizumab Approved DB14004
biotech | CAS: 1326244-10-3

Tildrakizumab is a high-affinity, humanized, IgG1 ? antibody targeting interleukin 23 p19 that shows promise in the evolution of treatment strategy in chronic plaque psoriasis [A32255]. The Food and Drug Administration (FDA) approved ILUMYA (tildrakizumab-…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +11
Target Protein:
Interleukin-23
Waktu ParuhThe half-life is ap…
Vol. DistribusiThe geometric mean …
KlirensThe mean (CV%) syst…
Genetik -
Tilmanocept Approved DB15373
small molecule | CAS: 1185986-76-8

Tilmanocept is under investigation in clinical trial NCT03241446 (Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tilmicosin DB11471
small molecule | CAS: 108050-54-0

Tilmicosin is a macrolide antibiotic. It is used in veterinary medicine for the treatment of bovine respiratory disease and ovine respiratory disease associated with _Mannheimia haemolytica_.

Kategori:
Anti-Bacterial AgentsAnti-Infective AgentsLactones +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tiludronic acid Approved DB01133
small molecule | CAS: 89987-06-4

Tiludronate, or (4-chlorophenyl)thio-methylene-1,1-bisphosphonate, is a first generation bisphosphonate similar to [etidronic acid] and [clodronic acid].[A1923,A203111] These drugs were developed to mimic the action of pyrophosphate, a regulator of calcificat…

Kategori:
BisphosphonatesBone Density Conservation AgentsDrugs Affecting Bone Structure and Mineralization +6
Target Protein:
HydroxylapatiteAdenosine triphosphate (ATP)Tyrosine-protein phosphatase non-receptor type 12 +3
Waktu ParuhThe mean plasma eli…
Vol. DistribusiThe volume of distr…
KlirensTiludronic acid has…
Genetik -
Tinzaparin Approved DB06822
small molecule | CAS: 9041-08-1

Tinzaparin is a low molecular weight heparin (LMWH), produced by enzymatic depolymerization of unfractionated heparin from porcine intestinal mucosa. It is a heterogeneous mixture of with an average molecular weight between 5500 and 7500 daltons. Tinzaparin i…

Kategori:
Agents causing hyperkalemiaAnticoagulantsBlood and Blood Forming Organs +8
Target Protein:
Antithrombin-IIIIntegrin alpha-4Stromal cell-derived factor 1
Waktu ParuhAnti-Xa activity is…
Vol. DistribusiAnti-Xa activity is…
KlirensClearance is dose-d…
Genetik -
Tiopronin Approved DB06823
small molecule | CAS: 1953-02-2

Tiopronin is a prescription thiol drug used primarily in the treatment of severe homozygous cystinuria. Patients with cystinuria excrete high levels of cystine in their urine and are at risk for kidney stone formation. Tiopronin is used as a second-line thera…

Kategori:
Amino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, Sulfur +7
Waktu ParuhTiopronin has a lon…
Vol. DistribusiThe volume of distr…
KlirensTotal renal clearan…
Genetik -
Tiotropium Approved DB01409
small molecule | CAS: 186691-13-4

Tiotropium is a long-acting, antimuscarinic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD) and asthma.[A180163,L7084,L7087,L7090,L7093] Tiotropium acts mainly on M3 muscarinic receptors located in the airways to produce …

Kategori:
Adrenergics, InhalantsAgents producing tachycardiaAgents to Treat Airway Disease +22
Target Protein:
Muscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M2 +2
Waktu ParuhThe terminal half l…
Vol. DistribusiThe volume of distr…
KlirensThe total clearance…
Genetik -
Tipiracil Approved DB09343
small molecule | CAS: 183204-74-2

Tipiracil is a thymidine phosphorylase inhibitor. It is used in combination with trifluridine, in a ratio of 1:0.5, to form TAS-102. The main function of Tipiracil in TAS-102 is to increase trifluridine bioavailability by inhibiting its catabolism.[A31255] TA…

Kategori:
MATE 1 SubstratesMATE 1 Substrates with a Narrow Therapeutic IndexMATE substrates +6
Target Protein:
Thymidine phosphorylase
Waktu ParuhAfter administratio…
Vol. DistribusiFollowing a single …
KlirensFollowing a single …
Genetik -
Tirapazamine DB04858
small molecule | CAS: 27314-97-2

Tirapazamine, also known as SR-4233, is an experimental anticancer drug that is activated in hypoxic conditions. This activation is very useful as this hypoxic state is found in human solid tumors in a common phenomenon known as tumor hypoxia. Hence, tirapaza…

Kategori:
Antineoplastic AgentsCytochrome P-450 CYP2E1 SubstratesCytochrome P-450 Substrates +2
Target Protein:
DNA topoisomerase 2-alphaDNA topoisomerase 2-betaDNA
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tiratricol DB03604
small molecule | CAS: 51-24-1

A metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome.

Kategori:
Agents used to treat hypothyroidismAmino AcidsAmino Acids, Aromatic +9
Target Protein:
Thyroid hormone receptor alphaThyroid hormone receptor beta
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tirbanibulin Approved DB06137
small molecule | CAS: 897016-82-9

Tirbanibulin (KX-O1 or KX2–391) is a dual inhibitor of Src Kinase and tubulin.[A225726] On December 14, 2020, tirbanibulin was approved by the FDA for the topical treatment of actinic keratosis on the face or scalp. It is marketed under the brand name Klisyri…

Kategori:
AcetatesAcids, AcyclicAmides +39
Target Protein:
Tubulin beta chainProto-oncogene tyrosine-protein kinase Src
Waktu ParuhThe half-life is ab…
Vol. DistribusiThere is limited in…
KlirensThere is limited in…
Genetik -
Tirzepatide Approved DB15171
biotech | CAS: 2023788-19-2

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Dual GIP/GLP-1 agonists gained increasing attention as new therapeutic agents for glycemic and weight control as they demonstr…

Kategori:
Alimentary Tract and MetabolismAmino Acids, Peptides, and ProteinsBlood Glucose Lowering Agents +17
Target Protein:
Glucagon-like peptide 1 receptorGastric inhibitory polypeptide receptor
Waktu ParuhThe half-life is ap…
Vol. DistribusiFollowing subcutane…
KlirensThe apparent popula…
Genetik -
Tisagenlecleucel Approved DB13881
biotech | CAS: 1823078-37-0

Tisagenlecleucel is a CD19-directed genetically modified autologous T cell immunotherapy, or a CAR-T cell therapy for B-cell acute lymphoblastic leukemia. It was granted approval by FDA in August 2017 under the market name Kymriah. Tisagenlecleucel is an immu…

Kategori:
Amino Acids, Peptides, and ProteinsAntineoplastic AgentsAntineoplastic Agents, Immunological +10
Target Protein:
B-lymphocyte antigen CD19
Waktu ParuhThe mean half life …
Vol. DistribusiThe drug is found t…
Klirens-
Genetik -
Tislelizumab Approved DB14922
biotech | CAS: 1858168-59-8

Tislelizumab is a humanized monoclonal IgG4 antibody against programmed death receptor-1 (PD-1). It was engineered to have a nullified Fc portion, thus minimizing binding to Fc?R on macrophages and limiting treatment resistance via antibody-dependent phagocyt…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +15
Target Protein:
Programmed cell death protein 1
Waktu ParuhBased on population…
Vol. DistribusiA population pharma…
KlirensBased on population…
Genetik -
Tisotumab vedotin Approved DB16732
biotech | CAS: 1418731-10-8

Tisotumab vedotin is a tissue factor-directed antibody-drug conjugate (ADC) comprised of an anti-tissue factor (TF) human IgG1-kappa antibody conjugated to monomethyl auristatin E (MMAE), a microtubule-disrupting agent, via a protease-cleavable valine-citrull…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +15
Target Protein:
Tissue factor
Waktu ParuhThe median terminal…
Vol. DistribusiThe tisotumab vedot…
KlirensThe linear clearanc…
Genetik -
Tivanisiran DB19105
biotech | CAS: 1848224-71-4

Tivanisiran is under investigation in clinical trial NCT03108664 (HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TM5614 DB16516
small molecule

TM5614 is a novel, orally active, plasminogen activator inhibitor 1 (PAI-1) inhibitor[A228788,A228793,]. PAI-1 is a marker of obesity, type 2 diabetes, and metabolic syndrome[L31673,A228793,A228798], and current studies are exploring downstream effects of its…

Kategori:
Experimental Unapproved Treatments for COVID-19
Target Protein:
Plasminogen activator inhibitor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TMC-310911 DB15623
small molecule | CAS: 1000287-05-7

TMC-310911 (also known as ASC-09) is a novel investigational protease inhibitor (PI) that is structurally similar to the currently available [darunavir].[L12045] It is being investigated for use in HIV-1 infections. TMC-310911 has shown marked activity agains…

Kategori:
Acids, AcyclicAmidesAnti-HIV Agents +10
Target Protein:
Gag-Pol polyproteinHIV-1 protease
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TNB-383B DB17268
biotech

TNB-383B is a CD3 and B-cell maturation antigen T-cell engaging bispecific antibody.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tobramycin Approved DB00684
small molecule | CAS: 32986-56-4

Aminoglycosides, many of which are derived directly from _Streptomyces_ spp., are concentration-dependent bactericidal antibiotics with a broad spectrum of activity against Gram-positive and Gram-negative organisms.[A232294] Inhaled tobramycin is notable for …

Kategori:
Agents that produce neuromuscular block (indirect)Aminoglycoside AntibacterialsAnti-Bacterial Agents +13
Target Protein:
16S ribosomal RNA23S ribosomal RNABacterial outer membrane +1
Waktu ParuhTobramycin has an a…
Vol. DistribusiInhalation tobramyc…
KlirensInhaled tobramycin …
Genetik -
Tocilizumab Approved DB06273
biotech | CAS: 375823-41-9

Tocilizumab is a recombinant humanized monoclonal antibody IL-6 receptor inhibitor used to treat inflammatory and autoimmune conditions.[L12789] It was first described in the literature in 2003 when Chugai, a subsidiary of Roche began developing IL-6 inhibiti…

Kategori:
Agents reducing cytokine levelsAmino Acids, Peptides, and ProteinsAntibodies +21
Target Protein:
Interleukin-6 receptor subunit alpha
Waktu ParuhThe half life of to…
Vol. DistribusiIn rheumatoid arthr…
KlirensThe linear clearanc…
Genetik -
Tocofersolan Approved DB11635
small molecule | CAS: 9002-96-4

D-Alpha-tocopheryl polyethylene glycol 1000 succinate (Tocofersolan, Vedrop), has been developed in Europe as an orally bioavailable source of vitamin E in children suffering from cholestasis [L2371]. Cholestasis is the reduction or stoppage of bile flow, eit…

Kategori:
Alimentary Tract and MetabolismBenzopyransCompounds used in a research, industrial, or household setting +9
Target Protein:
ATP-dependent translocase ABCB1
Waktu Paruh29.7 h [L2371]
Vol. DistribusiLocated principally…
Klirens-
Genetik -
Tofacitinib Approved DB08895
small molecule | CAS: 477600-75-2

Tofacitinib is an inhibitor of Janus kinases, a group of intracellular enzymes involved in signalling pathways that affect hematopoiesis and immune cell function. It is approved by the FDA for treatment of moderate to severe rheumatoid arthritis that responds…

Kategori:
Antineoplastic and Immunomodulating AgentsAntirheumatic AgentsBiologics for Rheumatoid Arthritis Treatment +14
Target Protein:
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2Tyrosine-protein kinase JAK3 +1
Waktu Paruh~3 hours
Vol. DistribusiVd= 87L after intra…
Klirens-
Genetik -
Tofersen Approved DB14782
biotech | CAS: 2088232-70-4

Tofersen is under an intrathecally administered antisense oligonucleotide targeting the mutated SOD1 gene that causes amyotrophic lateral sclerosis (ALS).[L46108] Although there were various causes of ALS, 2% of ALS cases are due to SOD1 mutations, with more …

Kategori:
Antisense OligonucleotidesNervous SystemNucleic Acids, Nucleotides, and Nucleosides +2
Target Protein:
Superoxide dismutase 1 (SOD1)
Waktu ParuhThe effective half-…
Vol. Distribusi-
Klirens-
Genetik -
Tolbutamide Approved DB01124
small molecule | CAS: 64-77-7

Tolbutamide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It is structurally similar to acetohexamide, chlorpropamide and tolazamide and belongs to the sulfonylurea class of insulin secretagogues…

Kategori:
Alimentary Tract and MetabolismAmidesBenzene Derivatives +25
Target Protein:
ATP-binding cassette sub-family C member 9ATP-binding cassette sub-family C member 8ATP-sensitive inward rectifier potassium channel 1
Gen Terkait:
CYP2C9
Waktu ParuhApproximately 7 hou…
Vol. Distribusi-
Klirens-
Genetik 1 Varian
biotech

Toll-like receptor 9 is under investigation in clinical trial NCT03007732 (Pembrolizumab in Combination With Intratumoral SD-101 Therapy).

Kategori:
Amino Acids, Peptides, and ProteinsDNA-Binding ProteinsMembrane Proteins +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tolperisone DB06264
small molecule | CAS: 728-88-1

Tolperisone is an oral, centrally acting muscle relaxant. Its precise mechanism is not completely understood, though it blocks sodium and calcium channels. It possesses a high affinity for nervous system tissue, reaching highest concentrations in brain stem, …

Kategori:
Central Nervous System AgentsCentral Nervous System DepressantsCytochrome P-450 CYP1A2 Substrates +10
Target Protein:
Sodium channel protein type 11 subunit alpha
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
TOP-1288 DB14839
small molecule | CAS: 1630202-02-6

TOP-1288 is under investigation in clinical trial NCT02888379 (Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Topiroxostat DB01685
small molecule | CAS: 577778-58-6

Topiroxostat is a selective xanthine oxidase inhibitor developed for treatment and management of hyperuricemia and gout. Xanthine oxidase, or xanthine oxidoreductase (XOR), regulates purine metabolism, and inhibition of the enzyme results in efficacious reduc…

Kategori:
BCRP/ABCG2 InhibitorsCytochrome P-450 CYP2C19 InhibitorsCytochrome P-450 CYP2C19 inhibitors (strength unknown) +13
Target Protein:
Xanthine dehydrogenase/oxidase
Waktu ParuhThe mean half life …
Vol. DistribusiThe mean ± SD appar…
KlirensThe apparent total …
Genetik -
Topramezone DB14826
small molecule | CAS: 210631-68-8

Topramezone is under investigation in clinical trial NCT00559520 (The Role of Preoperative Oral Immunonutrition in Major Vascular Surgery).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Toremifene Approved DB00539
small molecule | CAS: 89778-26-7

Toremifene is a selective estrogen receptor modulator (SERM) and a nonsteroidal antiestrogen used to treat estrogen receptor positive breast cancer.[A256923] Like [tamoxifen], toremifene is part of the first-generation triphenylethylene derivative chemical cl…

Kategori:
Anti-EstrogensAntineoplastic AgentsAntineoplastic Agents, Hormonal +23
Target Protein:
Estrogen receptorSex hormone-binding globulin
Waktu Paruh5 days
Vol. Distribusi* 580 L
Klirens* 5 L/h
Genetik -
Toripalimab Approved DB15043
biotech | CAS: 1924598-82-2

The proliferation of some cancers can be attributed, at least in part, to the suppression of host tumor surveillance. One mechanism by which this occurs is through the overexpression of programmed cell death ligand (PD-L1)[A261506] - the binding of PD-L1 (and…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +13
Target Protein:
Programmed cell death protein 1
Waktu ParuhThe mean terminal e…
Vol. DistribusiAt steady-state, th…
KlirensThe mean clearance …
Genetik -
Torudokimab DB16671
biotech | CAS: 2241728-76-5

Torudokimab is under investigation in clinical trial NCT03831191 (A Study of LY3375880 in Adults With Moderate-to-severe Atopic Dermatitis).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tosedostat DB11781
small molecule | CAS: 238750-77-1

Tosedostat has been used in trials studying the treatment and supportive care of AML, Leukemia, Pancreas Cancer, Multiple Myeloma, and Pancreatic Cancer, among others. Tosedostat is an inhibitor of the M1 family of aminopeptidases, in particular PuSA, and …

Kategori:
AminesAmino AcidsAmino Acids, Peptides, and Proteins +3
Target Protein:
Puromycin-sensitive aminopeptidaseLeukotriene A-4 hydrolase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Tovorafenib Approved DB15266
small molecule | CAS: 1096708-71-2

Tovorafenib is a selective type II RAF kinase inhibitor with anti-tumour activity.[A263597] It was granted accelerated approval by the FDA, making it the first FDA approval of a systemic therapy for the treatment of pediatric low-grade glioma, with BRAF rearr…

Kategori:
B-Raf serine-threonine kinase (BRAF) inhibitorsBCRP/ABCG2 InhibitorsCytochrome P-450 CYP1A2 Inducers +31
Target Protein:
RAF proto-oncogene serine/threonine-protein kinaseSerine/threonine-protein kinase A-RafSerine/threonine-protein kinase B-raf
Waktu ParuhTovorafenib termina…
Vol. DistribusiTovorafenib apparen…
KlirensThe apparent cleara…
Genetik -
Tozinameran Approved DB15696
biotech | CAS: 2417899-77-3

The Pfizer-BioNTech COVID-19 vaccine (also known as BNT162b2, Tozinameran, and Comirnaty), is one of four advanced mRNA-based vaccines developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002,L15007,L36025] Comirnaty is a nu…

Kategori:
Amino Acids, Peptides, and ProteinsAntigensBiological Factors +10
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Trabectedin Approved DB05109
small molecule | CAS: 114899-77-3

Trabectedin, also referred as ET-743 during its development, is a marine-derived antitumor agent discovered in the Carribean tunicate _Ecteinascidia turbinata_ and now produced synthetically. Trabectedin has a unique mechanism of action. It binds to the minor…

Kategori:
Agents Causing Muscle ToxicityAlkylating ActivityAlkylating Drugs +24
Target Protein:
DNA
Waktu Paruh33-50 hours
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 2451–2500 dari 2677
Sebelumnya Halaman 50 / 54 Berikutnya